CSNK1D

Across TCGA pan-cancer cohorts, CSNK1D mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CSNK1D data layer compared with 24 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CSNK1D mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated CSNK1D expression acts as an unfavorable survival marker, although some lineages such as LUAD and CCRCC show a favorable association.

LUAD, CCRCC, and UCEC are the cancer types where CSNK1D mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	1.000	0.868	.006	33	view →
CCRCC	DFS	Quartile	All	0.943	0.465	<.001	6	view →
UCEC	OS	Quartile	All	1.000	0.895	.032	4	view →
PDAC	OS	Tertile	III,IV	1.000	0.438	.013	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CSNK1D–LUAD (OS)

Open the LUAD breakdown →